Matrix Private Capital Group’s Novartis NVS Stock Holding History

Matrix Private Capital Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,233	Closed	-$204K	–	252
2021 Q2	$204K	Buy	+2,233	New	+$199K	0.11%	169
2021 Q1	–	Sell	-2,235	Closed	-$211K	–	244
2020 Q4	$211K	Sell	2,235 -198	-8%	-$17.3K	0.15%	148
2020 Q3	$212K	Sell	2,433 -7	-0.3%	-$606	0.22%	111
2020 Q2	$213K	Sell	2,440 -125	-5%	-$10.8K	0.23%	110
2020 Q1	$211K	Sell	2,565 -1,096	-30%	-$97.8K	0.3%	95
2019 Q4	$347K	Buy	+3,661	New	+$328K	0.36%	86

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Matrix Private Capital Group's NVS Position: Q3 2021 in Review

Matrix Private Capital Group sold out of Novartis (NVS) in Q3 2021, closing a stake of 2,233 shares — an estimated $204K sold.

Matrix Private Capital Group first reported a position in NVS in Q4 2019 and held it in 6 quarters. The position peaked at $347K in Q4 2019. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

Matrix Private Capital Group reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
Matrix Private Capital Group sold 2,233 Novartis shares in Q3 2021, an estimated $204K.
Matrix Private Capital Group first reported a position in Novartis in Q4 2019 and held it in 6 quarters.
Matrix Private Capital Group's Novartis position peaked at $347K in Q4 2019.
1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Matrix Private Capital Group's 13F filing for Q3 2021, filed 22 Feb 2022.